Related references
Note: Only part of the references are listed.CDK8 kinase-An emerging target in targeted cancer therapy
Tomasz Rzymski et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway
Adrian von Witzleben et al.
CANCER RESEARCH (2015)
Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma
A. M. Puzio-Kuter et al.
CELL DEATH AND DIFFERENTIATION (2015)
Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment
Todd VanArsdale et al.
CLINICAL CANCER RESEARCH (2015)
25-O-acetyl-23,24-dihydro-cucurbitacin F induces cell cycle G2/M arrest and apoptosis in human soft tissue sarcoma cells
Birgit Lohberger et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Richard S. Finn et al.
LANCET ONCOLOGY (2015)
Cyclin-dependent kinase 11p110 (CDK11p110) is crucial for human breast cancer cell proliferation and growth
Yubing Zhou et al.
SCIENTIFIC REPORTS (2015)
Targeting Cdk11 in Osteosarcoma Cells Using the CRISPR-cas9 System
Yong Feng et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2015)
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
Betsy T. Kren et al.
BREAST CANCER RESEARCH (2015)
ALS2CR7 (CDK15) attenuates TRAIL induced apoptosis by inducing phosphorylation of survivin Thr34
Mi Hee Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling
Yayun Chi et al.
BMC CANCER (2014)
Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions
Agnieszka K. Witkiewicz et al.
BREAST CANCER RESEARCH (2014)
Cyclin dependent kinase-9 mediated transcriptional de-regulation of cMYC as a critical determinant of endocrine-therapy resistance in breast cancers
Surojeet Sengupta et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Camilla L. Christensen et al.
CANCER CELL (2014)
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
Bin Jia et al.
CANCER LETTERS (2014)
Let-7a Functions as a Tumor Suppressor in Ewing's Sarcoma Cell Lines Partly by Targeting Cyclin-Dependent Kinase 6
Zhongzu Zhang et al.
DNA AND CELL BIOLOGY (2014)
Antiproliferative Effects of CDK4/6 Inhibition in CDK4-Amplified Human Liposarcoma In Vitro and In Vivo
Yi-Xiang Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Nicholas Kwiatkowski et al.
NATURE (2014)
Signaling through cyclin D-dependent kinases
Y. J. Choi et al.
ONCOGENE (2014)
CDK4 Amplification Predicts Recurrence of Well-Differentiated Liposarcoma of the Abdomen
Sanghoon Lee et al.
PLOS ONE (2014)
Cyclin D activates the Rb tumor suppressor by mono-phosphorylation
Anil M. Narasimha et al.
ELIFE (2014)
Structural characterization of the cyclin-dependent protein kinase family
Jane A. Endicott et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Osteosarcoma cells induce endothelial cell proliferation during neo-angiogenesis
Filomena de Nigris et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
A Cdk7-Cdk4 T-Loop Phosphorylation Cascade Promotes G1 Progression
Miriam Merzel Schachter et al.
MOLECULAR CELL (2013)
WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells
C. Mackintosh et al.
ONCOGENE (2013)
Cyclin-Dependent Kinase 4 Phosphorylates and Positively Regulates PAX3-FOXO1 in Human Alveolar Rhabdomyosarcoma Cells
Lingling Liu et al.
PLOS ONE (2013)
Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G2/M phase cell cycle arrest
Shui-er Zheng et al.
ACTA PHARMACOLOGICA SINICA (2012)
Prolonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4
Xiangao Huang et al.
BLOOD (2012)
The cyclin K/Cdk12 complex An emerging new player in the maintenance of genome stability
Dalibor Blazek
CELL CYCLE (2012)
Going out of the brain: Non-nervous system physiological and pathological functions of Cdk5
Erick Contreras-Vallejos et al.
CELLULAR SIGNALLING (2012)
Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation
Zhenfeng Duan et al.
CLINICAL CANCER RESEARCH (2012)
MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy
Steffan T. Nawrocki et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
MK1775, a Selective Wee1 Inhibitor, Shows Single-Agent Antitumor Activity against Sarcoma Cells
Jenny M. Kreahling et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II
Stephane Larochelle et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Updating the RNA polymerase CTD code: adding gene-specific layers
Sylvain Egloff et al.
TRENDS IN GENETICS (2012)
Cdk11-CyclinL Controls the Assembly of the RNA Polymerase II Mediator Complex
Julie Drogat et al.
CELL REPORTS (2012)
The Epidemiology of Sarcoma
Zachary Burningham et al.
CLINICAL SARCOMA RESEARCH (2012)
Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
Gottfried E. Konecny et al.
CLINICAL CANCER RESEARCH (2011)
The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes
Dalibor Blazek et al.
GENES & DEVELOPMENT (2011)
MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone
Fanny Dujardin et al.
MODERN PATHOLOGY (2011)
The Cyclin-Dependent Kinase Inhibitor SCH 727965 (Dinacliclib) Induces the Apoptosis of Osteosarcoma Cells
Wei Fu et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Angiogenic factor signaling regulates centrosome duplication in endothelial cells of developing blood vessels
Sarah M. Taylor et al.
BLOOD (2010)
Cyclin I-Cdk5 governs survival in post-mitotic cells
Paul T. Brinkkoetter et al.
CELL CYCLE (2010)
Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma
Jan Smida et al.
CLINICAL CANCER RESEARCH (2010)
Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Vladimir Krystof et al.
CURRENT DRUG TARGETS (2010)
p35 Is Required for CDK5 Activation in Cellular Senescence
Daqin Mao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
David Parry et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
J. L. Dean et al.
ONCOGENE (2010)
Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM
W. Ruprecht Wiedemeyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Emerging links between CDK cell cycle regulators and Wnt signaling
Gary Davidson et al.
TRENDS IN CELL BIOLOGY (2010)
Selective Elimination of Amplified CDK4 Sequences Correlates with Spontaneous Adipocytic Differentiation in Liposarcoma
Zofia Helias-Rodzewicz et al.
GENES CHROMOSOMES & CANCER (2009)
Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
Yvonne M. Schrage et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Transient treatment with CDK inhibitors eliminates proliferative potential even when their abilities to evoke apoptosis and DNA damage are blocked
Simon F. Scrace et al.
CELL CYCLE (2008)
CDK inhibitors: Cell cycle regulators and beyond
Arnaud Besson et al.
DEVELOPMENTAL CELL (2008)
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
Ron Firestein et al.
NATURE (2008)
Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor
Hongliang Zong et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Meriolins, a new class of cell death-inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases
Karima Bettayeb et al.
CANCER RESEARCH (2007)
Cdk1 is sufficient to drive the mammalian cell cycle
David Santamaria et al.
NATURE (2007)
The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines
Helen M. Coley et al.
GYNECOLOGIC ONCOLOGY (2007)
Synthesis and activity of quinolinyl-methylene-thiazolinones as potent and selective cyclin-dependent kinase 1 inhibitors
Shaoqing Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Aberrant expression of the Rb pathway proteins in soft tissue sarcomas
Muna Sabah et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2006)
Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells
Dongpo Cai et al.
CANCER RESEARCH (2006)
Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells
O. Pasder et al.
ONCOGENE (2006)
Chromosomal and genetic imbalances in synovial sarcoma detected by conventional and microarray comparative genomic hybridization
Yasuko Nakagawa et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Unmasking the redundancy between Cdk1 and Cdk2 at G2 phase in human cancer cell lines
Lawrence L'Italien et al.
CELL CYCLE (2006)
Cyclin-dependent kinase pathways as targets for cancer treatment
GI Shapiro
JOURNAL OF CLINICAL ONCOLOGY (2006)
AZ703, an imidazo[1,2-a]pyridine inhibitor of cyclin-dependent kinases 1 and 2, induces E2F-1-dependent apoptosis enhanced by depletion of cyclin-dependent kinase 9
DP Cai et al.
CANCER RESEARCH (2006)
Secrets of a double agent: CDK7 in cell-cycle control and transcription
RP Fisher
JOURNAL OF CELL SCIENCE (2005)
Mammalian cyclin-dependent kinases
M Malumbres et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Caffeic acid phenethyl ester (CAPE) prevents transformation of human cells by arsenite (As) and suppresses growth of As-transformed cells
CF Yang et al.
TOXICOLOGY (2005)
Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells
X Li et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Cdc2-cyclin E complexes regulate the G1/S phase transition
E Aleem et al.
NATURE CELL BIOLOGY (2005)
Cyclin H is targeted to the nucleus by C-terminal nuclear localization sequences
A Krempler et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2
XL Tang et al.
JOURNAL OF NEUROSCIENCE (2005)
CAK-cyclin-dependent activating kinase - A key kinase in cell cycle control and a target for drugs?
G Lolli et al.
CELL CYCLE (2005)
Cyclin-dependent kinase 9 is required for tumor necrosis factor-α-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells
B Shan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cyclin C/Cdk3 promotes Rb-dependent G0 exit
SJ Ren et al.
CELL (2004)
Cellular senescence requires CDK5 repression of Rac1 activity
K Alexander et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Mammalian cells cycle without the D-type cyclin-elependent kinases Cdk4 and Cdk6
M Malumbres et al.
CELL (2004)
Cellular control of gene expression by T-type cyclin/CDK9 complexes
J Garriga et al.
GENE (2004)
Human DNA damage checkpoints and their relevance to soft tissue sarcoma
H Hattori et al.
PATHOLOGY INTERNATIONAL (2004)
Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice
S Ortega et al.
NATURE GENETICS (2003)
CDK11 complexes promote pre-mRNA splicing
DL Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cyclin A in cell cycle control and cancer
CH Yam et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays
KL Schaefer et al.
VIRCHOWS ARCHIV (2002)
Cdk5 phosphorylates p53 and regulates its activity
JW Zhang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
To cycle or not to cycle: A critical decision in cancer
M Malumbres et al.
NATURE REVIEWS CANCER (2001)
TFIIH is negatively regulated by cdk8-containing mediator complexes
S Akoulitchev et al.
NATURE (2000)
Share Paper
